Skip to main content
Year archive

Oramed Pharmaceuticals Inc. — 2020 filings

All 112 regulatory filings released by Oramed Pharmaceuticals Inc. (ORMP) in 2020, sourced directly from the official regulator.

112 Filings
2020 Period
2020 filings (112)
Filing Released Lang
Reports Positive First in Human Data from Oral Leptin Study
Earnings Release FY 2020
2020-12-23 English
Reports Positive First in Human Data from Oral Leptin Study
Report Publication Announcement
2020-12-23 English
screened the first patients in a trial of ORMD-0801 for the treatment of NASH
Regulatory Filings
2020-12-02 English
screened the first patients in a trial of ORMD-0801 for the treatment of NASH
Report Publication Announcement
2020-12-02 English
CURRENT REPORT
Regulatory Filings
2020-12-02 English
Form 8K - Equity Distribution Agreement, dated December 1, 2020
Regulatory Filings
2020-12-01 English
Form 8K - Equity Distribution Agreement, dated December 1, 2020
Regulatory Filings
2020-12-01 English
Form 424B5 - PROSPECTUS SUPPLEMENT Dated December 1, 2020
Capital/Financing Update
2020-12-01 English
Form 424B5 - PROSPECTUS SUPPLEMENT Dated December 1, 2020
Capital/Financing Update
2020-12-01 English
CURRENT REPORT
Regulatory Filings
2020-12-01 English
PROSPECTUS SUPPLEMENT
Prospectus
2020-12-01 English
Initiates Phase 3 Trial of Oral Insulin
Earnings Release Q4 2020
2020-11-24 English
Initiates Phase 3 Trial of Oral Insulin
Report Publication Announcement
2020-11-24 English
FORM 10-K For the Fiscal Year Ended August 31, 2020
Annual Report FY 2020
2020-11-24 English
FORM 10-K For the Fiscal Year Ended August 31, 2020
Report Publication Announcement FY 2020
2020-11-24 English
ANNUAL REPORT
Annual Report FY 2020
2020-11-24 English
Investor Presentation dated October 22, 2020.
Investor Presentation
2020-10-23 English
Investor Presentation dated October 22, 2020.
Regulatory Filings
2020-10-23 English
CURRENT REPORT
Regulatory Filings
2020-10-22 English
Oramed Issues Shareholder Update on Pivotal Phase 3 Oral Insulin Studies: Protocols Submitted to FDA
Regulatory Filings
2020-10-18 English
Oramed Issues Shareholder Update on Pivotal Phase 3 Oral Insulin Studies: Protocols Submitted to FDA
Report Publication Announcement
2020-10-18 English
Clinical Research Organization Services Agreement dated September 2, 2020 and effective as of January 15, 2020, between Oramed Ltd. and Integrium, LLC.
Regulatory Filings
2020-09-21 English
Clinical Research Organization Services Agreement dated September 2, 2020 and effective as of January 15, 2020, between Oramed Ltd. and Integrium, LLC.
Regulatory Filings
2020-09-21 English
CURRENT REPORT
Regulatory Filings
2020-09-18 English
Oramed’s Diabetes Market Survey Shows Strong Support for ORMD-0801 Oral Insulin Among Physicians and Patients
Regulatory Filings
2020-09-15 English
Oramed’s Diabetes Market Survey Shows Strong Support for ORMD-0801 Oral Insulin Among Physicians and Patients
Report Publication Announcement
2020-09-15 English
Clinical Research Organization Services Agreement dated September 2, 2020 and effective as of January 15, 2020, between Oramed Ltd. and Integrium, LLC.
Regulatory Filings
2020-09-09 English
Clinical Research Organization Services Agreement dated September 2, 2020 and effective as of January 15, 2020, between Oramed Ltd. and Integrium, LLC.
Report Publication Announcement
2020-09-09 English
CURRENT REPORT
Regulatory Filings
2020-09-09 English
Letter from HTIT, disputing certain payment obligations of HTIT
Legal Proceedings Report
2020-08-27 English
Letter from HTIT, disputing certain payment obligations of HTIT
Report Publication Announcement
2020-08-27 English
CURRENT REPORT
Regulatory Filings
2020-08-27 English
FORM S-8-REGISTRATION STATEMENT
Share Issue/Capital Change
2020-08-12 English
FORM S-8-REGISTRATION STATEMENT
Regulatory Filings
2020-08-12 English
FORM S-8
Registration Form
2020-08-11 English
8-K Annual Meeting on August 3, 2020. The final voting results
AGM Information
2020-08-04 English
8-K Annual Meeting on August 3, 2020. The final voting results
Regulatory Filings
2020-08-04 English
FORM 8-K
Regulatory Filings
2020-08-04 English
Oramed Reports Positive End of Phase 2 Meeting With the FDA for Oral Insulin
Legal Proceedings Report
2020-07-15 English
Oramed Reports Positive End of Phase 2 Meeting With the FDA for Oral Insulin
Report Publication Announcement
2020-07-15 English
CURRENT REPORT
Regulatory Filings
2020-07-15 English
CONDENSED CONSOLIDATED FINANCIAL STATEMENTS AS OF MAY 31, 2020
Interim / Quarterly Report 9M 2020
2020-07-07 English
CONDENSED CONSOLIDATED FINANCIAL STATEMENTS AS OF MAY 31, 2020
Report Publication Announcement Q2 2020
2020-07-07 English
QUARTERLY REPORT
Interim / Quarterly Report Q3 2020
2020-07-07 English
Form DEF 14A - Definitive Proxy Statement
Proxy Solicitation & Information Statement
2020-06-30 English
Form DEF 14A - Definitive Proxy Statement
Remuneration Information
2020-06-30 English
DEFINITIVE PROXY STATEMENT
Proxy Solicitation & Information Statement
2020-06-30 English
Form DEF14A - Preliminary Proxy Statement
Remuneration Information
2020-06-17 English
Form DEF14A - Preliminary Proxy Statement
Remuneration Information
2020-06-17 English
PRELIMINARY PROXY STATEMENT
Regulatory Filings
2020-06-16 English
Oramed Announces Positive Initial Clinical Trial Results for Treatment of NASH with Oral Insulin
Regulatory Filings
2020-06-15 English
Oramed Announces Positive Initial Clinical Trial Results for Treatment of NASH with Oral Insulin
Report Publication Announcement
2020-06-15 English
Regulatory Filings 2020
Regulatory Filings
2020-05-01 English
Regulatory Filings 2020
Regulatory Filings
2020-05-01 English
CURRENT REPORT
Regulatory Filings
2020-04-09 English
Form 10-Q
Interim / Quarterly Report H1 2020
2020-04-06 English
Form 10-Q
Report Publication Announcement Q1 2020
2020-04-06 English
QUARTERLY REPORT
Interim / Quarterly Report Q2 2020
2020-04-06 English
Oramed Pharmaceuticals Issues CEO Shareholder Letter Providing Business Update Amid COVID-19
Legal Proceedings Report
2020-04-01 English
Oramed Pharmaceuticals Issues CEO Shareholder Letter Providing Business Update Amid COVID-19
Report Publication Announcement
2020-04-01 English
Oramed Receives Positive Feedback From End-of-Phase 2 Oral Insulin CMC Meeting With FDA
Earnings Release Q1 2020
2020-03-19 English
Oramed Receives Positive Feedback From End-of-Phase 2 Oral Insulin CMC Meeting With FDA
Report Publication Announcement
2020-03-19 English
Final Prospectus Supplement
Share Issue/Capital Change
2020-03-03 English
Final Prospectus Supplement
Capital/Financing Update
2020-03-03 English
PROSPECTUS SUPPLEMENT
Prospectus
2020-03-02 English
option to Underwriting the to purchase Company shares at the public offering price
Regulatory Filings
2020-03-01 English
option to Underwriting the to purchase Company shares at the public offering price
Report Publication Announcement
2020-03-01 English
CURRENT REPORT
Regulatory Filings
2020-02-28 English
PRICES PUBLIC OFFERING OF COMMON STOCK FOR AGGREGATE PROCEEDS OF $21 MILLION
Capital/Financing Update
2020-02-27 English
PRICES PUBLIC OFFERING OF COMMON STOCK FOR AGGREGATE PROCEEDS OF $21 MILLION
Report Publication Announcement
2020-02-27 English
ORAMED PHARMACEUTICALS INC. ANNOUNCES PROPOSED PUBLIC OFFERING OF COMMON STOCK
Share Issue/Capital Change
2020-02-26 English
ORAMED PHARMACEUTICALS INC. ANNOUNCES PROPOSED PUBLIC OFFERING OF COMMON STOCK
Report Publication Announcement
2020-02-26 English
PRELIMINARY PROSPECTUS SUPPLEMENT
Capital/Financing Update
2020-02-26 English
PRELIMINARY PROSPECTUS SUPPLEMENT
Regulatory Filings
2020-02-26 English
PROSPECTUS SUPPLEMENT
Prospectus
2020-02-26 English
Reports Positive Results in the Final Cohort of its Phase 2b Oral Insulin Trial
Earnings Release Q1 2020
2020-02-26 English
Reports Positive Results in the Final Cohort of its Phase 2b Oral Insulin Trial
Report Publication Announcement
2020-02-26 English
Form 8-K:Reports Positive Results in the Final Cohort of its Phase 2b Oral Insulin Trial
Regulatory Filings
2020-02-26 English
Form 8-K:Reports Positive Results in the Final Cohort of its Phase 2b Oral Insulin Trial
Report Publication Announcement
2020-02-26 English
CURRENT REPORT
Regulatory Filings
2020-02-26 English
AMENDMENT TO FORM SC 13G
Major Shareholding Notification
2020-02-14 English
SCHEDULE 13G
Major Shareholding Notification
2020-02-11 English
PROSPECTUS SUPPLEMENT (to prospectus dated February 10, 2020)
Capital/Financing Update
2020-02-11 English
PROSPECTUS SUPPLEMENT (to prospectus dated February 10, 2020)
Capital/Financing Update
2020-02-11 English
Regulatory Filings 2020
Regulatory Filings
2020-02-11 English
PROSPECTUS SUPPLEMENT
Prospectus
2020-02-10 English
Regulatory Filings 2020
Regulatory Filings
2020-02-06 English
Regulatory Filings 2020
Regulatory Filings
2020-02-04 English
FORM S-3-REGISTRATION STATEMENT
Capital/Financing Update
2020-02-02 English
FORM S-3-REGISTRATION STATEMENT
Report Publication Announcement
2020-02-02 English
REGISTRATION STATEMENT
Registration Form
2020-01-31 English
Oramed Appoints Dr. Julio Rosenstock to its Scientific Advisory Board
Board/Management Information
2020-01-30 English
Oramed Appoints Dr. Julio Rosenstock to its Scientific Advisory Board
Report Publication Announcement
2020-01-30 English
Oramed Patent in Europe to be Granted for Oral Delivery of Proteins
Regulatory Filings
2020-01-28 English
Oramed Patent in Europe to be Granted for Oral Delivery of Proteins
Report Publication Announcement
2020-01-28 English
SABBY 13G-A ORMP 1.21.20
Major Shareholding Notification
2020-01-21 English
Oramed Appoints Dr. Jay Skyler to Scientific Advisory Board
Board/Management Information
2020-01-21 English
Oramed Appoints Dr. Jay Skyler to Scientific Advisory Board
Report Publication Announcement
2020-01-21 English
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP
Major Shareholding Notification
2020-01-15 English
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP
Director's Dealing
2020-01-15 English
OWNERSHIP DOCUMENT
Director's Dealing
2020-01-14 English
OWNERSHIP DOCUMENT
Director's Dealing
2020-01-14 English
OWNERSHIP DOCUMENT
Director's Dealing
2020-01-14 English
OWNERSHIP DOCUMENT
Director's Dealing
2020-01-14 English
OWNERSHIP DOCUMENT
Director's Dealing
2020-01-14 English
OWNERSHIP DOCUMENT
Director's Dealing
2020-01-14 English
OWNERSHIP DOCUMENT
Director's Dealing
2020-01-14 English
Form 10-Q
Interim / Quarterly Report Q1 2020
2020-01-09 English
Form 10-Q
Report Publication Announcement
2020-01-09 English
QUARTERLY REPORT
Interim / Quarterly Report Q1 2020
2020-01-09 English
Oramed Pharmaceuticals Issues Letter to Shareholders
Legal Proceedings Report
2020-01-09 English
Oramed Pharmaceuticals Issues Letter to Shareholders
Regulatory Filings
2020-01-09 English